26.42
price down icon2.15%   -0.58
after-market Dopo l'orario di chiusura: 26.80 0.38 +1.44%
loading
Precedente Chiudi:
$27.00
Aprire:
$27.2
Volume 24 ore:
1.11M
Relative Volume:
0.75
Capitalizzazione di mercato:
$877.13M
Reddito:
$117.67M
Utile/perdita netta:
$-1.88B
Rapporto P/E:
-0.4364
EPS:
-60.5369
Flusso di cassa netto:
$-621.36M
1 W Prestazione:
+6.32%
1M Prestazione:
-12.78%
6M Prestazione:
+82.33%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$26.05
$27.92
Intervallo di 1 settimana:
Value
$24.75
$27.92
Portata 52W:
Value
$12.33
$63.99

Grail Inc Stock (GRAL) Company Profile

Name
Nome
Grail Inc
Name
Telefono
(833) 694-2553
Name
Indirizzo
1525 O'BRIEN DRIVE, MENLO PARK
Name
Dipendente
1,000
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
GRAL's Discussions on Twitter

Confronta GRAL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
GRAL
Grail Inc
26.42 877.13M 117.67M -1.88B -621.36M -60.54
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
421.85 169.62B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
184.96 138.06B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
406.65 32.79B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
100.26 29.99B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
141.22 26.61B 15.41B 1.37B 2.11B 7.50

Grail Inc Stock (GRAL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-27 Iniziato Morgan Stanley Equal-Weight
2024-11-15 Iniziato Wolfe Research Peer Perform
2024-10-17 Iniziato Guggenheim Neutral

Grail Inc Borsa (GRAL) Ultime notizie

pulisher
Apr 21, 2025

This Cancer Test Could Become Routine—and a Big Seller, Says Analyst - Barron's

Apr 21, 2025
pulisher
Apr 21, 2025

Canaccord sets $32 target on GRAIL stock with buy rating By Investing.com - Investing.com Nigeria

Apr 21, 2025
pulisher
Apr 21, 2025

Canaccord starts Grail with a Buy, sees ‘solid upside’ - TipRanks

Apr 21, 2025
pulisher
Apr 21, 2025

Canaccord Genuity Initiates GRAIL at Buy With $32 Price Target - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

Canaccord sets $32 target on GRAIL stock with buy rating - Investing.com Australia

Apr 21, 2025
pulisher
Apr 16, 2025

GRAIL, Inc. (GRAL): A Bull Case Theory - Insider Monkey

Apr 16, 2025
pulisher
Apr 16, 2025

Form DEF 14A GRAIL, Inc. For: May 29 - StreetInsider

Apr 16, 2025
pulisher
Apr 12, 2025

GRAIL's Galleri Progresses While Back In Accumulation Levels - Seeking Alpha

Apr 12, 2025
pulisher
Apr 09, 2025

AI-Powered Studio GRAiL Launched By Davide Bianca & Jeff Krelitz - Deadline

Apr 09, 2025
pulisher
Apr 08, 2025

How Does GRAIL Benefit From The Proposed MCED Legislation? (NASDAQ:GRAL) - Seeking Alpha

Apr 08, 2025
pulisher
Apr 06, 2025

Multi-Cancer Early Detection Market Critical Analysis with Expert Opinion| GRAIL, Natera, Elypta - openPR.com

Apr 06, 2025
pulisher
Mar 31, 2025

Jim Cramer Likes GRAIL, Inc. (GRAL) Despite Losses – Great Science, Risky Bet! - Yahoo Finance

Mar 31, 2025
pulisher
Mar 29, 2025

Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 billion deal - MarketScreener

Mar 29, 2025
pulisher
Mar 27, 2025

A Sydney company’s laser focus on energy’s holy grail - @AuManufacturing

Mar 27, 2025
pulisher
Mar 25, 2025

Opinion | One ‘Monopoly’ That Could Save Your Life - The Wall Street Journal

Mar 25, 2025
pulisher
Mar 21, 2025

Is GRAIL Stock About to Skyrocket? - timothysykes.com

Mar 21, 2025
pulisher
Mar 20, 2025

GRAIL Careers, Perks + Culture - Built In

Mar 20, 2025
pulisher
Mar 19, 2025

Debate Over Multi-Cancer Screening Tests Shifts Pending Grail Randomized Trial Results - GenomeWeb

Mar 19, 2025
pulisher
Mar 18, 2025

FDA approval remains Holy Grail for Aussie biotechs - NT News

Mar 18, 2025
pulisher
Mar 18, 2025

Biocurious: FDA approval remains the Holy Grail for ASX life science stocks - Stockhead

Mar 18, 2025
pulisher
Mar 18, 2025

Grail price target raised to $20 from $16 at Morgan Stanley - TipRanks

Mar 18, 2025
pulisher
Mar 16, 2025

Have Insiders Sold GRAIL Shares Recently? - Simply Wall St

Mar 16, 2025
pulisher
Mar 16, 2025

Jim Cramer On Netflix, Inc. (NFLX) – Subscription Is the Holy Grail—Netflix Is Doing Very Well! - Insider Monkey

Mar 16, 2025
pulisher
Mar 16, 2025

Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN

Mar 16, 2025
pulisher
Mar 13, 2025

Grail president Joshua Ofman sells $65,800 in common stock By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 12, 2025

Grail CEO Robert Ragusa sells $237,976 in stock By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 12, 2025

Grail CEO Robert Ragusa sells $237,976 in stock - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

Grail president Joshua Ofman sells $65,800 in common stock - Investing.com

Mar 12, 2025
pulisher
Mar 10, 2025

Oppenheimer & Co. Inc. Invests $190,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Rhumbline Advisers Makes New Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

New York State Common Retirement Fund Makes New $59,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World

Mar 07, 2025
pulisher
Mar 04, 2025

Grail’s Stock Surge: An Eye on Future Moves - timothysykes.com

Mar 04, 2025
pulisher
Mar 03, 2025

GRALGrail Inc Latest Stock News & Market Updates - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

Is GRAIL, Inc. (GRAL) Among Jeff Bezos’ Investments in 2025? - Yahoo Finance

Mar 03, 2025
pulisher
Mar 02, 2025

Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In - Insider Monkey

Mar 02, 2025
pulisher
Feb 28, 2025

Ieq Capital LLC Acquires Shares of 19,874 Grail, Inc. (NASDAQ:GRAL) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Grail (NASDAQ:GRAL) Trading 9.8% HigherWhat's Next? - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire

Feb 26, 2025
pulisher
Feb 25, 2025

Grail goes ‘Grey’s’: Actor Kate Walsh joins awareness campaign for multi-cancer early detection testing - FiercePharma

Feb 25, 2025
pulisher
Feb 25, 2025

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing - Longview News-Journal

Feb 25, 2025
pulisher
Feb 25, 2025

Grail projects FDA submission completion for Galleri by H1 2026 with expanded scalability - MSN

Feb 25, 2025
pulisher
Feb 24, 2025

GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025 - Insider Monkey

Feb 24, 2025
pulisher
Feb 24, 2025

Why Grail (GRAL) Is Falling Today - MSN

Feb 24, 2025
pulisher
Feb 23, 2025

Van ECK Associates Corp Takes $475,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World

Feb 23, 2025
pulisher
Feb 22, 2025

Grail initiated at equal weight by Morgan Stanley - MSN

Feb 22, 2025
pulisher
Feb 21, 2025

Can GRAIL's Cancer Detection Technology Transform Healthcare? Key Presentation Coming March 4 - StockTitan

Feb 21, 2025
pulisher
Feb 21, 2025

Putting early cancer detection to the test - Nature.com

Feb 21, 2025
pulisher
Feb 20, 2025

GRAIL Q4 Loss Narrows, Revenue Up; Shares Rise After-Hours - MarketScreener

Feb 20, 2025
pulisher
Feb 20, 2025

Earnings call transcript: Grail’s Q4 2024 revenue rises, stock surges - Investing.com

Feb 20, 2025

Grail Inc Azioni (GRAL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research DGX
$161.86
price down icon 1.18%
diagnostics_research WAT
$316.23
price down icon 1.49%
diagnostics_research LH
$212.22
price down icon 2.26%
$142.23
price down icon 3.95%
diagnostics_research MTD
$970.15
price down icon 3.46%
diagnostics_research IQV
$141.22
price down icon 1.87%
Capitalizzazione:     |  Volume (24 ore):